Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Sectoral/ Thematic median (252 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 01 Jul 2025 – 20 Aug 2026, limited by Baroda BNP Paribas Health and Wellness Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Baroda BNP Paribas Health and Wellness Fund | Nifty 500 |
|---|---|---|
| 01 Jul 2025 | ₹100.00 | ₹100.00 |
| 05 Aug 2025 | ₹98.54 | ₹96.54 |
| 08 Sep 2025 | ₹97.33 | ₹96.88 |
| 13 Oct 2025 | ₹97.15 | ₹98.64 |
| 16 Nov 2025 | ₹96.53 | ₹100.94 |
| 21 Dec 2025 | ₹94.04 | ₹100.26 |
| 25 Jan 2026 | ₹90.45 | ₹96.15 |
| 28 Feb 2026 | ₹95.63 | ₹98.10 |
| 04 Apr 2026 | ₹89.51 | ₹88.66 |
| 08 May 2026 | ₹98.56 | ₹97.88 |
| 12 Jun 2026 | ₹100.18 | ₹95.70 |
| 16 Jul 2026 | ₹106.09 | ₹98.38 |
| 20 Aug 2026 | ₹106.84 | ₹99.57 |
| Metric | Baroda BNP Paribas · Regular NAV ₹10.69 Very High risk ★★★★☆ 1Y | Category median Sectoral/ Thematic · 252 funds |
|---|---|---|
| +8.36% | +5.83% | |
| — | +15.63% | |
| — | +13.23% | |
| — | +13.85% | |
| +6.00% | +12.26% | |
| +17.69% | — | |
| — | +15.60% | |
| — | +14.52% | |
| — | +13.74% | |
| Risk | ||
| 11.50% | 15.62% | |
| 0.16 | 0.43 | |
| 0.22 | 0.59 | |
| -11.93% | -23.65% | |
| Nifty 500 | — | |
| — | +3.42% | |
| — | 0.95 | |
| — | 105.9% | |
| — | 93.6% | |
| 2.79% | 2.39% | |
| ₹538.60Cr | ₹1,161Cr | |
| Up to 1.00% | — | |
| None | — | |
| ₹500 | — | |
| ₹1.00K | — | |
| 86% | 45% | |
| Rohan Korde · 0.3y | — | |
| 01 Jul 2025 | — | |
| 31 | — | |
| 54.7% | — | |
| -0.6% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.